Langerhans cell-dendritic cell cross-talk via langerin and hyaluronic acid mediates antigen transfer and cross-presentation of HIV-1

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1763-1773

  Van Den Berg, Linda M ^a   Cardinaud, Sylvain ^b,c,d   Van Der Aar, Angelic M G ^a   Sprokholt, Joris K ^a   De Jong, Marein A W P ^a   Zijlstra Willems, Esther M ^a   Moris, Arnaud ^b,c,d,e   Geijtenbeek, Teunis B H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d Assistance publique Hôpitaux de Paris   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 2; LANGERIN; PATTERN RECOGNITION RECEPTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN; CD207 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LECTIN; LEUKOCYTE ANTIGEN; LIGAND; MANNOSE BINDING LECTIN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNE RESPONSE; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ANALYSIS; UPREGULATION; ANTIGEN PRESENTATION; CELL COMMUNICATION; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM;

ANTIGEN PRESENTATION; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CROSS-PRIMING; DENDRITIC CELLS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; HYALURONIC ACID; LANGERHANS CELLS; LECTINS, C-TYPE; LIGANDS; MANNOSE-BINDING LECTINS; PROTEIN BINDING;

EID: 84938907944     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402356     Document Type: Article

References (50)

1. deWitte, L., A. Nabatov, M. Pion, D. Fluitsma, M. A. W. P. de Jong, T. de Gruijl, V. Piguet, Y. van Kooyk, and T. B. H. Geijtenbeek. 2007. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13: 367-371.
2. Daniels, T. E. 1984. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J. Invest. Dermatol. 82: 21-24.
3. Kawamura, T., S. E. Kurtz, A. Blauvelt, and S. Shimada. 2005. The role of Langerhans cells in the sexual transmission of HIV. J. Dermatol. Sci. 40: 147-155.
4. de Jong, M. A. W. P., L. de Witte, M. J. Oudhoff, S. I. Gringhuis, P. Gallay, and T. B. H. Geijtenbeek. 2008. TNF-A and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J. Clin. Invest. 118: 3440-3452.
5. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
6. de Jong, M. A. W. P., L. E. M. Vriend, B. Theelen, M. E. Taylor, D. Fluitsma, T. Boekhout, and T. B. H. Geijtenbeek. 2010. C-type lectin Langerin is a bglucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol. Immunol. 47: 1216-1225.
7. van der Vlist, M., and T. B. H. Geijtenbeek. 2010. Langerin functions as an antiviral receptor on Langerhans cells. Immunol. Cell Biol. 88: 410-415.
8. de Jong, M. A. W. P., L. de Witte, M. E. Taylor, and T. B. H. Geijtenbeek. 2010. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. J. Immunol. 185: 1633-1641.
9. Geijtenbeek, T. B. H., R. Torensma, S. J. van Vliet, G. C. F. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
10. Willment, J. A., S. Gordon, and G. D. Brown. 2001. Characterization of the human b-glucan receptor and its alternatively spliced isoforms. J. Biol. Chem. 276: 43818-43823.
11. Stoitzner, P., S. Holzmann, A. D. McLellan, L. Ivarsson, H. Stössel, M. Kapp, U. Kämmerer, P. Douillard, E. Kämpgen, F. Koch, et al. 2003. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120: 266-274.
12. Stambach, N. S., and M. E. Taylor. 2003. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology 13: 401-410.
13. Hunger, R. E., P. A. Sieling, M. T. Ochoa, M. Sugaya, A. E. Burdick, T. H. Rea, P. J. Brennan, J. T. Belisle, A. Blauvelt, S. A. Porcelli, and R. L. Modlin. 2004. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113: 701-708.
14. van der Vlist, M., L. de Witte, R. D. de Vries, M. Litjens, M. A. W. P. de Jong, D. Fluitsma, R. L. de Swart, and T. B. H. Geijtenbeek. 2011. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4? T cells but are incapable of cross-presentation. Eur. J. Immunol. 41: 2619-2631.
15. van den Berg, L. M., C. M. Ribeiro, E. M. Zijlstra-Willems, L. de Witte, D. Fluitsma, W. Tigchelaar, V. Everts, and T. B. Geijtenbeek. 2014. Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells. Retrovirology 11: 3903.
16. Ogawa, Y., T. Kawamura, T. Matsuzawa, R. Aoki, P. Gee, A. Yamashita, K. Moriishi, K. Yamasaki, Y. Koyanagi, A. Blauvelt, and S. Shimada. 2013. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe 13: 77-86.
17. Ogawa, Y., T. Kawamura, T. Kimura, M. Ito, A. Blauvelt, and S. Shimada. 2009. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113: 5157-5166.
18. Nasr, N., J. Lai, R. A. Botting, S. K. Mercier, A. N. Harman, M. Kim, S. Turville, R. J. Center, T. Domagala, P. R. Gorry, et al. 2014. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin. J. Immunol. 193: 2554-2564.
19. Peressin, M., A. Proust, S. Schmidt, B. Su, M. Lambotin, M. E. Biedma, G. Laumond, T. Decoville, V. Holl, and C. Moog. 2014. Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes. AIDS 28: 667-677.
20. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
21. Allan, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Villadangos, Y. Zhan, A. M. Lew, K. Shortman, W. R. Heath, and F. R. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
22. Allan, R. S., C. M. Smith, G. T. Belz, A. L. van Lint, L. M. Wakim, W. R. Heath, and F. R. Carbone. 2003. Epidermal viral immunity induced by CD8a+ dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
23. Geijtenbeek, T. B. H., G. C. F. van Duijnhoven, S. J. van Vliet, E. Krieger, G. Vriend, C. G. Figdor, and Y. van Kooyk. 2002. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J. Biol. Chem. 277: 11314-11320.
24. Rodriguez-Plata, M. T., A. Urrutia, S. Cardinaud, M. J. Buzón, N. Izquierdo-Useros, J. G. Prado, M. C. Puertas, I. Erkizia, P. G. Coulon, S. Cedeño, et al. 2012. HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activation. J. Immunol. 188: 6036-6045.
25. Moris, A., C. Nobile, F. Buseyne, F. Porrot, J. P. Abastado, and O. Schwartz. 2004. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103: 2648-2654.
26. Maréchal, V., F. Clavel, J. M. Heard, and O. Schwartz. 1998. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72: 2208-2212.
27. Gringhuis, S. I., J. den Dunnen, M. Litjens, M. van der Vlist, B. Wevers, S. C. M. Bruijns, and T. B. H. Geijtenbeek. 2009. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kB activation through Raf-1 and Syk. Nat. Immunol. 10: 203-213.
28. Casartelli, N., F. Guivel-Benhassine, R. Bouziat, S. Brandler, O. Schwartz, and A. Moris. 2010. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J. Exp. Med. 207: 39-49.
29. Taylor, K. R., and R. L. Gallo. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20: 9-22.
30. Andre, B., C. Duterme, K. Van Moer, J. Mertens-Strijthagen, M. Jadot, and B. Flamion. 2011. Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raftassociated hyaluronidase. Biochem. Biophys. Res. Commun. 411: 175-179.
31. Csoka, A. B., G. I. Frost, and R. Stern. 2001. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20: 499-508.
32. Harada, H., and M. Takahashi. 2007. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. J. Biol. Chem. 282: 5597-5607.
33. Bedoui, S., P. G. Whitney, J. Waithman, L. Eidsmo, L. Wakim, I. Caminschi, R. S. Allan, M. Wojtasiak, K. Shortman, F. R. Carbone, et al. 2009. Crosspresentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10: 488-495.
34. Feinberg, H., M. E. Taylor, N. Razi, R. McBride, Y. A. Knirel, S. A. Graham, K. Drickamer, and W. I. Weis. 2011. Structural basis for langerin recognition of diverse pathogen and mammalian glycans through a single binding site. J. Mol. Biol. 405: 1027-1039.
35. Sayo, T., Y. Sugiyama, Y. Takahashi, N. Ozawa, S. Sakai, O. Ishikawa, M. Tamura, and S. Inoue. 2002. Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J. Invest. Dermatol. 118: 43-48.
36. Mummert, M. E., D. Mummert, D. Edelbaum, F. Hui, H. Matsue, and A. Takashima. 2002. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169: 4322-4331.
37. Kaya, G., C. Tran, O. Sorg, R. Hotz, D. Grand, P. Carraux, L. Didierjean, I. Stamenkovic, and J. H. Saurat. 2006. Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS Med. 3: e493.
38. Stern, R. 2003. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 13: 105R-115R.
39. Mc Dermott, R., U. Ziylan, D. Spehner, H. Bausinger, D. Lipsker, M. Mommaas, J. P. Cazenave, G. Raposo, B. Goud, H. de la Salle, et al. 2002. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol. Biol. Cell 13: 317-335.
40. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
41. Sprecher, E., and Y. Becker. 1989. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch. Virol. 107: 191-205.
42. Matsuo, M., Y. Nagata, E. Sato, D. Atanackovic, D. Valmori, Y. T. Chen, G. Ritter, I. Mellman, L. J. Old, and S. Gnjatic. 2004. IFN-g enables crosspresentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proc. Natl. Acad. Sci. USA 101: 14467-14472.
43. Ratzinger, G., J. Baggers, M. A. de Cos, J. Yuan, T. Dao, J. L. Reagan, C. Münz, G. Heller, and J. W. Young. 2004. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J. Immunol. 173: 2780-2791.
44. Fausch, S. C., D. M. Da Silva, and W. M. Kast. 2003. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res. 63: 3478-3482.
45. Klechevsky, E., R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A. K. Palucka, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29: 497-510.
46. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188: 2163-2173.
47. Fleeton, M. N., N. Contractor, F. Leon, J. D. Wetzel, T. S. Dermody, and B. L. Kelsall. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200: 235-245.
48. Bosnjak, L., M. Miranda-Saksena, D. M. Koelle, R. A. Boadle, C. A. Jones, and A. L. Cunningham. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174: 2220-2227.
49. Davis, D. M. 2007. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 7: 238-243.
50. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593.